Naturally occurring and induced osteoarthritis: Behavioural and functional modification measured through pain and mobility assessment, pressure mat technology, radiographic imaging, changes in inflammatory markers in synovial fluid

Stress, Fear and Anxiety: Evaluation of calming or anxiolytic therapeutics or devices using thunderstorm and car travel models through evaluations such as serum cortisol, continuous heart rate, and behavioural assessment

Longevity and Brain aging: Assessment of therapeutic interventions for improving or delaying age-dependent cognitive decline and cognitive dysfunction syndrome (CDS) combined with the ability to sample and analyze CSF and plasma for biomarkers

Induced Diabetes, feeding and weight disorder studies including weight management, satiety, glucose tolerance and insulin sensitivity

Dermatological studies assessing induced and naturally occurring pruritis with CADESI scoring

Periodontal disease including assessment of pocket depth, gum disease scoring, collection of GCF, tarter and plaque and dental x-ray

Vaccine efficacy studies

PK / PD and dose-finding studies with in-house bioanalysis capabilities

Bio-sampling and processing (blood, urine, feces, saliva) for microbiome studies

Target animal palatability, acceptability and safety of therapeutics, supplements or specific ingredients

Cognitive and behavioural development over the first year of life with ability to look at in utero effects of supplements and drugs

Access to in vivo imaging modalities including MRI, PET, SPECT, and microCT

Dog eletroencephalography (EEG) for non-GLP assessment of seizure threshold, sleep / wake profiling, and safety

"Coming soon": Telemetric assessment of cardiovascular parameters in dogs